SENORES PHARMACEUTICALS L (SENORES) — Capital Reinvestment Ratio
SENORES PHARMACEUTICALS L (SENORES) has a Capital Reinvestment Ratio of 3.99x as of September 2025, meaning it reinvests 4% of its operating cash flow (Rs242.20 Million) in capital expenditures (Rs966.90 Million). Check SENORES tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
SENORES PHARMACEUTICALS L Capital Reinvestment Ratio (2026–2026)
This chart tracks SENORES PHARMACEUTICALS L's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see SENORES operating cash flow.
Annual Capital Reinvestment Ratio for SENORES PHARMACEUTICALS L (2026–2026)
Year-by-year Capital Reinvestment Ratio for SENORES PHARMACEUTICALS L from 2026 to 2026. See SENORES free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 4.27x | Rs620.50 Million | Rs2.65 Billion | — |